Philip Jones, Ph.D., vice president of Therapeutics Discovery and head of the Institute for Applied Cancer Science, designed a hydrocarbon-stapled peptide, SP9, to block Syt2, based on structures developed by the Stanford collaborators, including senior co-corresponding author Axel Brunger, Ph.D., professor of Molecular and Cellular Physiology
The staff is extremely helpful, knowledgeable and friendly as well
Start with your study goals, then match your dosage accordingly
In-Office & Adjunctive Topical Protocols AMP therapy in dentistry is primarily delivered topically as rinses, gels, or locally applied agents during periodontal procedures
There is one open-label intravenous safety pilot in two healthy adults, who received single doses of 10 mg and 20 mg with no comparator, no blinding, and short-term observation limited to vital signs, self reported symptoms and labs across two days [4]